alexa
Reach Us +1-504-608-2390
Fish Oil For The Secondary Prevention Of Cardiovascular Events: A Met Analysis | 7924
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Fish oil for the secondary prevention of cardiovascular events: a met analysis

International Conference & Exhibition on Clinical Research Dermatology, Ophthalmology & Cardiology

Andr?s Vicente

ScientificTracks Abstracts: JCEC

DOI: 10.4172/2155-9880.S1.01

Abstract
Coronary Heart Disease is currently the leading cause of morbidity and mortality worldwide. Two met analyses have already supported the effectiveness of fish oil on dyslipidemia. Several studies have been conducted to determine the efficacy of fish oil in reducing cardiovascular outcomes. This meta-analysis aims to determine the efficacy of fish oil in reducing cardiovascular events, specifically sudden cardiac death, fatal and non-fatal myocardial infarction, unstable angina pectoris, need for revascularization, rest enosis rate after percutaneous transluminal coronary angiography (PTCA), combined major coronary events, and all-cause mortality. All randomized, controlled trials assessing the effects of fish oil supplementation as secondary prevention of cardiovascular events among adults are included in this study. There is no racial or gender preference. Studies on primary prevention were excluded. Diet-based strategies were excluded as well. The outcomes of the included studies are cardiovascular deaths, fatal or non fatal myocardial infarction, unstable angina, need for revascularization and rest enosis. Thorough search of available online databases (Pub Med, Cochrane, Embasse, Google, ClinicalTrials.gov) was done using the search terms fish oil [MeSH: fatty acids, omega 3, Docosahexaenoic acids, eicosapentaenoic acids] and myocardial ischemia [MeSH: acute coronary syndrome, angina pectoris, unstable angina, coronary disease, myocardial infarction, myocardial reperfusion injury, myocardial stunning]. The search was limited to all RCTs among adults done from Prevention of all cause mortality was also significant in the fish oi l group (RR 0.79, CI: 0.69, 0.92, I2= 0%).
Biography
Andr?s Vicente received his doctor in Biological Sciences from the University of Barcelona in 1990. During his postdoctoral tra ining at Children?s Hospital, Harvard University (1991-1994) and St. Elizabeth?s Medical Center of Tufts University (1994-1995), conducted studies on the role of homeobox transcription factors and MEF2 in differentiation and cell proliferation. At this stage he began his interest in the r esearch area cardiovascular.In 1995 was promoted to Assistant Professor of Medicine at Tufts University and began his career as an independe nt researcher. Since then Dr. Andrew and his group have studied the vascular remodeling during atherosclerosis and restenosis post-angioplasty . After obtaining a position as Research Associate at the Cardiovascular Research Council, Dr. Andres returned to Spain in 1999 to establish his re search group at the Institute of Biomedicine of Valencia, where he worked as Research Professor. Since 2006 his group is a member of the Research T hematic Network
Top